Please use this identifier to cite or link to this item:
https://hdl.handle.net/11055/624Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hayes, C | en_US |
| dc.date.accessioned | 2018-07-18T03:42:55Z | - |
| dc.date.available | 2018-07-18T03:42:55Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | 4(2):27-30 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11055/624 | - |
| dc.description.abstract | Guidelines suggest that opioids may be trialled in patients with chronic noncancer pain if expected benefits outweigh the risks. This article addresses how this guidance should be interpreted given the lack of evidence of efficacy and the clear evidence of harm from long-term opioid use. | en_US |
| dc.subject | Chronic Pain | en_US |
| dc.subject | Opioids | en_US |
| dc.subject | Guidelines | en_US |
| dc.title | Chronic noncancer pain: the challenge of implementing opioid guidelines | en_US |
| dc.type | Journal Article | en_US |
| dc.type.content | Text | en_US |
| dc.identifier.journaltitle | Pain Management Today | en_US |
| dc.type.studyortrial | Case Control Studies | en_US |
| dc.contributor.anzcaadd | Hayes, C | en_US |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | No Fulltext | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | none | - |
| item.openairetype | Journal Article | - |
| Appears in Collections: | Scholarly and Clinical | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.